Cargando…

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection

BACKGROUND: Traditional Chinese medicine injections (TCMIs) have been widely used to treat severe and acute diseases due to their high bioavailability, accurate curative effect, and rapid effect. However, incidence rates of adverse drug reactions (ADRs) of TCMIs have also increased in recent years....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chunxiao, Xu, Tao, Zhou, Peng, Zhang, Junhua, Guan, Ge, Zhang, Hui, Ling, Xiao, Li, Weixia, Meng, Fei, Liu, Guanping, Lv, Linyan, Yuan, Jun, Li, Xuelin, Zhu, Mingjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192149/ https://www.ncbi.nlm.nih.gov/pubmed/30326892 http://dx.doi.org/10.1186/s12906-018-2329-z

Ejemplares similares

Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment
por: Lyu, Jian, et al.
Publicado: (2020)

Xueshuantong Injection in Treating Deep Venous Thrombosis: A Systematic Review and Trial Sequential Analysis
por: Li, Wenhui, et al.
Publicado: (2021)

Neuroprotective Effect of Xueshuantong for Injection (Lyophilized) in Transient and Permanent Rat Cerebral Ischemia Model
por: Wang, Xumei, et al.
Publicado: (2015)

The efficacy and safety of Xueshuantong (lyophilized) for injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis
por: Xi, Junyu, et al.
Publicado: (2023)

Protective Effects of Fufang Xueshuantong on Diabetic Retinopathy in Rats
por: Duan, Huihui, et al.
Publicado: (2013)

Proteomic analysis revealed the pharmacological mechanism of Xueshuantong injection in preventing early acute myocardial infarction injury
por: Wang, Aoao, et al.
Publicado: (2022)

Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design
por: Feng, Luda, et al.
Publicado: (2021)

Anti-thrombosis Effects and Mechanisms by Xueshuantong Capsule Under Different Flow Conditions
por: Han, Shuxian, et al.
Publicado: (2019)

Xueshuantong improves cerebral blood perfusion in elderly patients with lacunar infarction★
por: Gui, Qifeng, et al.
Publicado: (2013)

Clinical Efficacy of Xueshuantong plus Urokinase in the Treatment of Sudden Deafness
por: Wang, Yanling, et al.
Publicado: (2022)

Exploring the Mechanism of Action Compound-Xueshuantong Capsule in Diabetic Retinopathy Treatment Based on Network Pharmacology
por: Li, Haoran, et al.
Publicado: (2020)

Fufang Xueshuantong Improves Diabetic Cardiomyopathy by Regulating the Wnt/β-Catenin Pathway
por: Peng, Meizhong, et al.
Publicado: (2022)

Retracted: Clinical Efficacy of Xueshuantong plus Urokinase in the Treatment of Sudden Deafness
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Meta-Analysis of Randomized Controlled Trials of Xueshuantong Injection in Prevention of Deep Venous Thrombosis of Lower Extremity after Orthopedic Surgery
por: Yan, Shu-ting, et al.
Publicado: (2020)

Efficacy and safety of Fufang Xueshuantong Capsules in combination with conventional drugs in the treatment of glaucoma: A meta-analysis and trial sequential analysis
por: Zeng, Zhicheng, et al.
Publicado: (2023)

Xueshuantong Improves Functions of Lymphatic Ducts and Modulates Inflammatory Responses in Alzheimer’s Disease Mice
por: Zheng, Rui, et al.
Publicado: (2021)

Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration
por: Pan, Hai-Tao, et al.
Publicado: (2020)

Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme
por: Sheng, Shujing, et al.
Publicado: (2014)

UPLC-QTOF/MS(E) and Bioassay Are Available Approaches for Identifying Quality Fluctuation of Xueshuantong Lyophilized Powder in Clinic
por: Yang, Zhi-Rui, et al.
Publicado: (2018)

Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases
por: Li, Xue-Lin, et al.
Publicado: (2015)

Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer’s Disease Mice
por: Huang, Yangmei, et al.
Publicado: (2018)

Inhibition of Shear-Induced Platelet Aggregation by Xueshuantong via Targeting Piezo1 Channel-Mediated Ca(2+) Signaling Pathway
por: Liu, Lei, et al.
Publicado: (2021)

Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023)

Data-Dependent Acquisition and Database-Driven Efficient Peak Annotation for the Comprehensive Profiling and Characterization of the Multicomponents from Compound Xueshuantong Capsule by UHPLC/IM-QTOF-MS
por: Zuo, Tiantian, et al.
Publicado: (2019)

Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy
por: Yao, Hongyan, et al.
Publicado: (2021)

Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study
por: Yu, Zaoqin, et al.
Publicado: (2021)

Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
por: Li, Jin, et al.
Publicado: (2022)

Investigation into the potential mechanism and molecular targets of Fufang Xueshuantong capsule for the treatment of ischemic stroke based on network pharmacology and molecular docking
por: Wang, Lei, et al.
Publicado: (2022)

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
por: Meng, Fan-Ya, et al.
Publicado: (2017)

Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020)

Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
por: Albalawi, Omar M., et al.
Publicado: (2022)

An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
por: Younus, Manal Mohammed, et al.
Publicado: (2021)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy
por: Long, Wenjie, et al.
Publicado: (2020)

Core Bioactive Components Promoting Blood Circulation in the Traditional Chinese Medicine Compound Xueshuantong Capsule (CXC) Based on the Relevance Analysis between Chemical HPLC Fingerprint and In Vivo Biological Effects
por: Liu, Hong, et al.
Publicado: (2014)

Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China
por: Hu, Ran, et al.
Publicado: (2023)

Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance
por: Bo, Qijing, et al.
Publicado: (2023)

Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study
por: Lee, Hye Jin, et al.
Publicado: (2015)

Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

Wet Markets and Food Safety: TripAdvisor for Improved Global Digital Surveillance
por: Kogan, Nicole E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p2srolvokagminlllmkbpu6a73